Serca Pharmaceuticals is a biopharmaceutical company developing a novel cardioprotective drug candidate, 13-M, for the treatment of acute myocardial infarction
Serca Pharmaceuticals is a biopharmaceutical company developing a novel cardioprotective drug candidate, 13-M, for the treatment of acute myocardial infarction.